-
Signature
-
/s/ Florian Brand, Chief Executive Officer of ATAI Life Sciences B.V. and ATAI Life Sciences AG
-
Stock symbol
-
IGXT
-
Transactions as of
-
May 14, 2021
-
Transactions value $
-
$0
-
Form type
-
3
-
Date filed
-
5/24/2021, 04:57 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
holding |
IGXT |
Common Stock, $0.00001 par value per share |
|
|
|
|
|
37.3M |
May 14, 2021 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
holding |
IGXT |
Warrant (Right to Buy) |
|
|
|
|
|
|
May 14, 2021 |
Common Stock, $0.00001 par value |
22.4M |
$0.35 |
Direct |
F1, F2 |
holding |
IGXT |
Warrant (Right to Buy) |
|
|
|
|
|
|
May 14, 2021 |
Common Stock, $0.00001 par value |
130M |
|
Direct |
F1, F3 |
holding |
IGXT |
Warrant (Right to Buy) |
|
|
|
|
|
|
May 14, 2021 |
Common Stock, $0.00001 par value |
|
|
Direct |
F1, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
In April 2021, ATAI Life Sciences AG was acquired by ATAI Life Sciences B.V. as a consequence of a capital increase of ATAI Life Sciences B.V. in the context of which the shareholders of ATAI Life Sciences AG contributed and transferred their shares in ATAI Life Sciences AG as a contribution in kind to ATAI Life Sciences B.V., resulting in ATAI Life Sciences AG becoming a wholly-owned subsidiary of ATAI Life Sciences B.V. and the shareholders of ATAI Life Sciences AG becoming the shareholders of ATAI Life Sciences B.V. Accordingly, this Form 3 has been filed on behalf of ATAI Life Sciences AG and ATAI Life Sciences B.V.